{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20240618",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "78831",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/103792Orig1s5354;761106Orig1s010ltr.pdf",
              "date": "20240620",
              "type": "Letter"
            },
            {
              "id": "78852",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761106s010lbl.pdf",
              "date": "20240620",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190228",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "57834",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761106Orig1s000lbl.pdf",
              "date": "20190228",
              "type": "Label"
            },
            {
              "id": "57864",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761106Orig1s000ltr.pdf",
              "date": "20190301",
              "type": "Letter"
            },
            {
              "id": "60577",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761106Orig1s000TOC.html",
              "date": "20191017",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "BLA761106",
      "sponsor_name": "GENENTECH INC",
      "openfda": {
        "application_number": [
          "BLA761106"
        ],
        "brand_name": [
          "HERCEPTIN HYLECTA"
        ],
        "generic_name": [
          "TRASTUZUMAB AND HYALURONIDASE-OYSK"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-077"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "HYALURONIDASE (HUMAN RECOMBINANT)",
          "TRASTUZUMAB"
        ],
        "rxcui": [
          "2119714",
          "2119719"
        ],
        "spl_id": [
          "6f91c20d-3654-4d9f-bfda-557364b1e7ea"
        ],
        "spl_set_id": [
          "ebf30894-41cf-480c-8bc3-56f592a13813"
        ],
        "package_ndc": [
          "50242-077-01"
        ],
        "nui": [
          "N0000175531",
          "M0009499",
          "N0000175661",
          "N0000020008"
        ],
        "pharm_class_epc": [
          "Endoglycosidase [EPC]",
          "HER2/neu Receptor Antagonist [EPC]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "pharm_class_moa": [
          "HER2/Neu/cerbB2 Antagonists [MoA]"
        ],
        "unii": [
          "743QUY4VD8",
          "P188ANX8CK"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "HERCEPTIN HYLECTA",
          "active_ingredients": [
            {
              "name": "TRASTUZUMAB AND HYALURONIDASE-OYSK",
              "strength": "600MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}